Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through β1 integrin

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1635-1641

  Ellerbroek, Shawn M ^a   Fishman, David A ^a   Kearns, Alicia S ^a   Bafetti, Lisa M ^a   Stack, M Sharon ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; GELATINASE A; INTEGRIN; MATRIX METALLOPROTEINASE 14; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL AGGREGATION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

EID: 0033119050     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Moser, T. L., Pizzo, S. V., Batetti, L. M., Fishman, D. A., and Stack, M. S. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the α2β1 integrin. Int. J. Cancer, 67: 695-701, 1996.
2. Auersperg, N., Maines-Bandiera, S. L., and Kruk, P. A. Human surface epithelium: growth patterns and differentiation. In: F. Sharp, P. Mason, T. Blacket, and J. Berek (eds.), Ovarian Cancer III, pp. 157-169. London: Chapman & Hall, 1994.
3. Stack, M. S., Ellerbrock, S. M., and Fishman, D. A. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int. J. Oncol., 12: 569-576, 1998.
4. Woessner, J. F., Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5: 2145-2154, 1991.
5. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. Matrix metalloproleinases: a review. Crit. Rev. Oral Biol. Med., 4: 197-250, 1993.
6. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., Jr., and Stetler-Stevenson, W. G. MMP-2: expression, activation and inhibition. Enzyme Protein, 49: 7-19, 1996.
7. Nagase, H. Activation mechanisms of matrix melalloproleinases. Biol. Chem., 378: 151-160, 1997.
8. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61-55, 1994.
9. Zucker, S., Drews, M., Conner, C., Foda, H. D., DeClerck, Y. A., Langley, K. E., Bahou, W. F., Docherty, A., and Cao, J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1 matrix metalloproteinase 1 (MT1-MMP). J. Biol Chem., 273: 1216-1222, 1998.
10. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M. P., and Murphy, G. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol Chem., 273: 871-880, 1998.
11. Kinoshita, T., Sato, H., Okadam A., Ohuchi, E., Imai, K., Okada, Y., and Seiki, M. J. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol Chem., 273: 16098-16103, 1998.
12. Sato, H., Kinoshita, T., Takino, T., Nakayama, K., and Seiki, M. Activation of a recombinant membrane type-I matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of matrix metalloproteinase (TIMP)-2. FEBS Lett., 393: 101-104, 1996.
13. Maquoi, E., Noel, A., Frankenne, F., Angliker, H., Murphy, G., and Foidart, J. M. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett., 424: 262-266, 1998.
14. Lafrenie, R. M., and Yamada, K. M. Integrin-dependent signal transduction. J. Cell. Biochem., 61: 543-553, 1996.
15. Price, J. T., Bonovich, M. T., and Kohn, E. C. The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol., 32: 175-253, 1997.
16. Miyamato, S., Akiyama, S. K., and Yamada, K. M. Synergistic roles for receptor occupancy and aggregation in inlegrin transmembrane function. Science (Washington DC), 267: 883-885, 1995.
17. Humphries, M. J. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol., 8: 632-640, 1996.
18. LaFlamme, S. E., Akiyama, S. K., and Yamada, K. M. Regulation of fibronectin receptor distribution. J. Cell Biol., 117: 437-447, 1992.
19. Miyamato, S., Teramoto, H., Coso, O. A., Silvio Gutkind, J., Burbelo, P. D., Akiyama, S. K., and Yamada, K. M. Integrin functions: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol., 131: 791-805, 1995.
20. r 72,000 type IV collagenase in normal and malignant fibroblastoid cells. Cancer Res., 52: 4540-4544, 1992.
21. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. W. Implication of collagen type I-induced membrane-type-1 matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest., 76: 651-660, 1997.
22. Tomesek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu, T. K., Liu, R. W., and Howard, E. W. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem., 272: 7482-7787, 1997.
23. Haas, T. L., Davis, S. J., and Madri, J. A. Three-dimensional type I collagen lattice induces coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 273: 3604-3610, 1998.
24. Seltzer, J. L., Lee, A. Y., Akers, K. T., Sudbeck, B., Southon, E. A., Wayner, E. A., and Eisen, A. Z. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res., 213: 365-374, 1994.
25. Seftor, R. E. B., Seftor, E. A., Stetler-Stevenson, W. G., and Hendrix, M. J. C. The 72Kda type IV collagenase is modulated via differential expression of αVβ3 and α5β1 integrins during human melanoma cell invasion. Cancer Res., 53: 3411-3415, 1993.
26. Larjava, H., Lyons, J. G., Sato, T., Mekela, M., Koivisto, L., Birkedal-Hansen, H., Akiyama, S. K., Yamada, K. M., and Heino, J. Anti-integrin antibodies induce type IV collagenase expression in keralinocytes. J. Cell. Physiol., 157: 190-200, 1993.
27. Chintala, S. K., Sawaya, R., Gokaslan, Z. L., and Rao, J. S. Modulation of matrix metalloproteinase-2 and invasion in human glioma cells by α3β1 integrin. Cancer Lett. 102: 201-208, 1996.
28. Afzal, S., Lalani, E. N., Poulsom, R., Stubbs, A., Rowlinson, G., Sato, H., Seiki, M., and Stamp, G. W. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum. Pathol., 29: 155-165, 1998.
29. Fishman, D. A., Bafetti, L. M., and Stack, M. S. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis. 16: 150-159, 1996.
30. Moser, T. L., Young, T. N., Rodriguez, G. C., Pizzo, S. V., Bast, R. C., and Stack, M. S. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int. J. Cancer. 56: 552-559, 1994.
31. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592-5595, 1987.
32. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
33. Matsudaira, P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem., 262: 10035-10038, 1987.
34. Staatz, W. D., Fok, K. F., Zuller, M. M., Adams, S. P., Rodriguez, B. A., and Santoro, S. A. Identification of a tetrapetide recognition sequence for the α2β1 integrin in collagen. J. Biol. Chem., 266: 7363-7367, 1991.
35. Friedl, P., Maaser, K., Eberhard Klein, C., Niggemann, B., Krohne, G., and Zanker, K. S. Migration of highly aggressive MV3 melanoma cell invasion in three-dimensional collagen lattices results in local matrix reorganization and shedding of α2 and β1 integrins and CD44. Cancer Res., 57: 2061-2070, 1997.
36. ras upon antibody-mediated α2β1 integrin activation in T-lymphoblastc cells. J. Biol. Chem., 268: 20701-20704, 1993.
37. Carter, W. G., Wayner, E. A., Bouchard, T. S., and Kaur, P. The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell Biol., 110: 1387-1404, 1990.
38. Stanton, H., Gavrilovic, J., Atkinson, S. J., d'Ortho, M. P., Yamada, K. M., Zardi, L., and Murphy, G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci., 111: 2789-2798, 1998.
39. Lauer, J. L., Gendron, C. M., and Fields, G. B. Effects of ligand conformation on melanoma cell α3β1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion. Biochemistry, 37: 5279-5281, 1998.
40. Overall, C. M., and Sodek, J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J. Biol. Chem., 265: 21141-21151.
41. Yu, M., Sato, H., Seiki, M., and Thompson, K. W. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res., 55: 3272-3277, 1995.
42. Lohi, J., Lehti, K., Westermarck, J., Kahari, V., and Keski-Oja, J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem., 239: 239-247, 1996.
43. Lehti, K., Lohi, J., Valtanen, H., and Keski-Oja, J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J., 334: 345-353, 1998.
44. d'Ortho, M. P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., and Murphy, G. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem., 250, 751-757, 1997.
45. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem., 272: 2446-2451, 1997.